ENDRA Life Sciences Inc

NDRA12 Dec 2024
Healthcare
$4.94
-0.04 (-3.83%)
Lowest Today
$4.66
Highest Today
$5.08
Today’s Open
$4.94
Prev. Close
$4.96
52 Week High
$4882.5
52 Week Low
$4.01
To Invest in ENDRA Life Sciences Inc

ENDRA Life Sciences Inc

Healthcare
NDRA12 Dec 2024
-0.04 (-3.83%)
1M
3M
6M
1Y
5Y
Low
$4.66
Day’s Range
High
$5.08
4.66
52 Week Low
$4.01
52-Week Range
52 Week High
$4882.5
4.01
1 Day
-
1 Week
-4.47%
1 month return
-22.95%
3 month return
+1812.12%
6 month return
+3994.07%
1 Year return
+221.91%
3 Years return
-71.33%
5 Years return
-77.61%
10 Years return
-
Institutional Holdings
Jane Street Group LLC
0.01
Fidelity Extended Market Index
0.01
Vanguard Institutional Extnd Mkt Idx Tr
0
Fidelity Series Total Market Index
0
Northern Trust Extended Eq Market Idx
0
NT Ext Equity Mkt Idx Fd - L
0
NT Ext Equity Mkt Idx Fd - NL
0

Market Status

Fundamentals
Market Cap
2.66 mln
PB Ratio
0.4
PE Ratio
0
Enterprise Value
-1.9 mln
Total Assets
6.75 mln
Volume

Company Financials

Fund house & investment objective

Company Information
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Organisation
ENDRA Life Sciences Inc
Employees
21
Industry
Diagnostics & Research
CEO
Mr. Alexander Y. Tokman
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step